Key facts
- This page summarizes Gerald Bagg's Form 3 filing for Cure Pharmaceutical Holding Corp. (AVRW).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Aug 2022, 12:25.
Gerald Bagg - 22 Jul 2022 Form 3 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)
- Reporting relationship
- Director
- Issuer ticker
- AVRW
- Reported as of
- 22 Jul 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 23 Aug 2022, 12:25:45 UTC
- Next SEC filing
- 15 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joel M. Bennett, attorney-in-fact for Gerald Bagg
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gerald Bagg filed Form 3 for Cure Pharmaceutical Holding Corp. (AVRW) on 23 Aug 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
No securities are beneficially owned. Exhibit 24 - Power of Attorney